BIOMAT Database Logo BIOMAT Database Logo

Thrombogenic potential of Innovia polymer valves versus Carpentier-Edwards Perimount Magna aortic bioprosthetic valves. 2011

Thomas E Claiborne, and Gaurav Girdhar, and Siobhain Gallocher-Lowe, and Jawaad Sheriff, and Yasushi P Kato, and Leonard Pinchuk, and Richard T Schoephoerster, and Jolyon Jesty, and Danny Bluestein
Department of Biomedical Engineering, Stony Brook University, Stony Brook, New York 11794-8181, USA.

Trileaflet polymeric prosthetic aortic valves (AVs) produce hemodynamic characteristics akin to the natural AV and may be most suitable for applications such as transcatheter implantation and mechanical circulatory support (MCS) devices. Their success has not yet been realized due to problems of calcification, durability, and thrombosis. We address the latter by comparing the platelet activation rates (PARs) of an improved polymer valve design (Innovia LLC) made from poly(styrene-block-isobutylene-block-styrene) (SIBS) with the commercially available Carpentier-Edwards Perimount Magna Aortic Bioprosthetic Valve. We used our modified prothrombinase platelet activity state (PAS) assay and flow cytometry methods to measure platelet activation of a pair of 19 mm valves mounted inside a pulsatile Berlin left ventricular assist device (LVAD). The PAR of the polymer valve measured with the PAS assay was fivefold lower than that of the tissue valve (p = 0.005) and fourfold lower with flow cytometry measurements (p = 0.007). In vitro hydrodynamic tests showed clinically similar performance of the Innovia and Magna valves. These results demonstrate a significant improvement in thrombogenic performance of the polymer valve compared with our previous study of the former valve design and encourage further development of SIBS for use in heart valve prostheses.

UI MeSH Term Description Entries
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D011474 Prosthesis Design The plan and delineation of prostheses in general or a specific prosthesis. Design, Prosthesis,Designs, Prosthesis,Prosthesis Designs
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006353 Heart-Assist Devices Small pumps, often implantable, designed for temporarily assisting the heart, usually the LEFT VENTRICLE, to pump blood. They consist of a pumping chamber and a power source, which may be partially or totally external to the body and activated by electromagnetic motors. Artificial Ventricle,Heart Assist Device,Heart Ventricle, Artificial,Pumps, Heart-Assist,Vascular-Assist Device,Vascular-Assist Devices,Ventricle-Assist Device,Ventricular Assist Device,Artificial Heart Ventricle,Artificial Heart Ventricles,Artificial Ventricles,Assist Device, Heart,Assist Device, Ventricular,Assist Devices, Heart,Assist Devices, Ventricular,Device, Heart Assist,Device, Heart-Assist,Device, Vascular-Assist,Device, Ventricle-Assist,Device, Ventricular Assist,Devices, Heart Assist,Devices, Heart-Assist,Devices, Vascular-Assist,Devices, Ventricle-Assist,Devices, Ventricular Assist,Heart Assist Devices,Heart Ventricles, Artificial,Heart-Assist Device,Heart-Assist Pump,Heart-Assist Pumps,Pump, Heart-Assist,Pumps, Heart Assist,Vascular Assist Device,Vascular Assist Devices,Ventricle Assist Device,Ventricle, Artificial,Ventricle, Artificial Heart,Ventricle-Assist Devices,Ventricles, Artificial,Ventricles, Artificial Heart,Ventricular Assist Devices
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001021 Aortic Valve The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle. Aortic Valves,Valve, Aortic,Valves, Aortic
D001705 Bioprosthesis Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers. Glutaraldehyde-Stabilized Grafts,Heterograft Bioprosthesis,Porcine Xenograft Bioprosthesis,Xenograft Bioprosthesis,Bioprostheses,Bioprostheses, Heterograft,Bioprostheses, Porcine Xenograft,Bioprostheses, Xenograft,Bioprosthesis, Heterograft,Bioprosthesis, Porcine Xenograft,Bioprosthesis, Xenograft,Glutaraldehyde Stabilized Grafts,Glutaraldehyde-Stabilized Graft,Graft, Glutaraldehyde-Stabilized,Grafts, Glutaraldehyde-Stabilized,Heterograft Bioprostheses,Porcine Xenograft Bioprostheses,Xenograft Bioprostheses,Xenograft Bioprostheses, Porcine,Xenograft Bioprosthesis, Porcine
D013343 Styrenes Derivatives and polymers of styrene. They are used in the manufacturing of synthetic rubber, plastics, and resins. Some of the polymers form the skeletal structures for ion exchange resin beads.
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

Thomas E Claiborne, and Gaurav Girdhar, and Siobhain Gallocher-Lowe, and Jawaad Sheriff, and Yasushi P Kato, and Leonard Pinchuk, and Richard T Schoephoerster, and Jolyon Jesty, and Danny Bluestein
Leaflet Mechanical Properties of Carpentier-Edwards Perimount Magna Pericardial Aortic Bioprostheses.
January 2017, The Journal of heart valve disease,
Thomas E Claiborne, and Gaurav Girdhar, and Siobhain Gallocher-Lowe, and Jawaad Sheriff, and Yasushi P Kato, and Leonard Pinchuk, and Richard T Schoephoerster, and Jolyon Jesty, and Danny Bluestein
Primary echocardiographic results of the Carpentier-Edwards Perimount Magna.
July 2012, Journal of medical ultrasonics (2001),
Thomas E Claiborne, and Gaurav Girdhar, and Siobhain Gallocher-Lowe, and Jawaad Sheriff, and Yasushi P Kato, and Leonard Pinchuk, and Richard T Schoephoerster, and Jolyon Jesty, and Danny Bluestein
Carpentier-Edwards Perimount Magna valve versus Medtronic Hancock II: a matched hemodynamic comparison.
June 2007, The Annals of thoracic surgery,
Thomas E Claiborne, and Gaurav Girdhar, and Siobhain Gallocher-Lowe, and Jawaad Sheriff, and Yasushi P Kato, and Leonard Pinchuk, and Richard T Schoephoerster, and Jolyon Jesty, and Danny Bluestein
Carpentier-Edwards Perimount valves--morphological findings in surgical explants.
January 2007, Journal of cardiac surgery,
Thomas E Claiborne, and Gaurav Girdhar, and Siobhain Gallocher-Lowe, and Jawaad Sheriff, and Yasushi P Kato, and Leonard Pinchuk, and Richard T Schoephoerster, and Jolyon Jesty, and Danny Bluestein
St. Jude Trifecta versus Carpentier-Edwards Perimount Magna valves for the treatment of aortic stenosis: comparison of early Doppler-echocardiography and hemodynamic performance.
September 2013, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace,
Thomas E Claiborne, and Gaurav Girdhar, and Siobhain Gallocher-Lowe, and Jawaad Sheriff, and Yasushi P Kato, and Leonard Pinchuk, and Richard T Schoephoerster, and Jolyon Jesty, and Danny Bluestein
The new St Jude Trifecta versus Carpentier-Edwards Perimount Magna and Magna Ease aortic bioprosthesis: is there a hemodynamic superiority?
May 2014, The Journal of thoracic and cardiovascular surgery,
Thomas E Claiborne, and Gaurav Girdhar, and Siobhain Gallocher-Lowe, and Jawaad Sheriff, and Yasushi P Kato, and Leonard Pinchuk, and Richard T Schoephoerster, and Jolyon Jesty, and Danny Bluestein
Cuff leakage, not paravalvular leakage, in the Carpentier Edwards PERIMOUNT Magna Ease aortic bioprosthesis.
December 2015, Interactive cardiovascular and thoracic surgery,
Thomas E Claiborne, and Gaurav Girdhar, and Siobhain Gallocher-Lowe, and Jawaad Sheriff, and Yasushi P Kato, and Leonard Pinchuk, and Richard T Schoephoerster, and Jolyon Jesty, and Danny Bluestein
Trifecta versus Perimount Magna Ease aortic valves: Failure mechanisms.
September 2022, Asian cardiovascular & thoracic annals,
Thomas E Claiborne, and Gaurav Girdhar, and Siobhain Gallocher-Lowe, and Jawaad Sheriff, and Yasushi P Kato, and Leonard Pinchuk, and Richard T Schoephoerster, and Jolyon Jesty, and Danny Bluestein
Eight-year outcomes of aortic valve replacement with the Carpentier-Edwards PERIMOUNT Magna Ease valve.
December 2022, Journal of cardiac surgery,
Thomas E Claiborne, and Gaurav Girdhar, and Siobhain Gallocher-Lowe, and Jawaad Sheriff, and Yasushi P Kato, and Leonard Pinchuk, and Richard T Schoephoerster, and Jolyon Jesty, and Danny Bluestein
Randomized, prospective assessment of bioprosthetic valve durability. Hancock versus Carpentier-Edwards valves.
November 1993, Circulation,
Copied contents to your clipboard!